Search research articles
Contact Us
Filters
Showing results (151-160 of 203) with videos related to
Page
of 21
Sort By:
Transplantation and Cellular Therapy
|
December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
Jacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Expert Opinion on Biological Therapy
|
May 17, 2017
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
Francesca Patriarca, Luisa Giaccone, Francesco Onida, et al.
American Journal of Hematology
|
November 18, 2022
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT
Michele Wieczorek, Myriam Labopin, Luca Castagna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2017
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Carmen Martínez, Jorge Gayoso, Carmen Canals, et al.
Bone Marrow Transplantation
|
November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
Luca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Leukemia
|
December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
Peter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.
Leukemia & Lymphoma
|
March 8, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study
Alessandra Tucci, Alessandro Re, Chiara Pagani, et al.
Blood Advances
|
April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma
Chiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
Bone Marrow Transplantation
|
June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)
Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Haematologica
|
July 8, 2021
Single-cell profiling reveals the dynamics of cytomegalovirus-specific T cells in haploidentical hematopoietic stem cell transplantation
Jasper J P Van Beek, Simone Puccio, Alessandra Roberto, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 203) with videos related to
Sort By:
Page
of 21
Transplantation and Cellular Therapy
|
December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
Jacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Expert Opinion on Biological Therapy
|
May 17, 2017
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
Francesca Patriarca, Luisa Giaccone, Francesco Onida, et al.
American Journal of Hematology
|
November 18, 2022
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT
Michele Wieczorek, Myriam Labopin, Luca Castagna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2017
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Carmen Martínez, Jorge Gayoso, Carmen Canals, et al.
Bone Marrow Transplantation
|
November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
Luca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Leukemia
|
December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
Peter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.
Leukemia & Lymphoma
|
March 8, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study
Alessandra Tucci, Alessandro Re, Chiara Pagani, et al.
Blood Advances
|
April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma
Chiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
Bone Marrow Transplantation
|
June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)
Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Haematologica
|
July 8, 2021
Single-cell profiling reveals the dynamics of cytomegalovirus-specific T cells in haploidentical hematopoietic stem cell transplantation
Jasper J P Van Beek, Simone Puccio, Alessandra Roberto, et al.
Page
of 21